🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Avidity Biosciences, Inc.

Avidity Biosciences, Inc. logo
Market Cap: High
Employees: Low

AOC 1001, AOC 1044, AOC 1020, Lumizyme

Avidity Biosciences, Inc. is a biopharmaceutical company focused on the development of oligonucleotide-based therapies, including antibody oligonucleotide conjugates (AOC) for serious diseases such as myotonic dystrophy type 1, Duchenne Muscular Dystrophy, and facioscapulohumeral muscular dystrophy.

Tags: Duchenne Muscular Dystrophy, Pompe disease, antibody oligonucleotide conjugates, biopharmaceutical, facioscapulohumeral muscular dystrophy, myotonic dystrophy, oligonucleotide, therapies

Symbol: RNA

Recent Price: $29.18

Industry: Biotechnology

CEO: Ms. Sarah Boyce

Sector: Healthcare

Employees: 253

Address: 10578 Science Center Drive, San Diego, CA 92121

Phone: 858 401 7900

Leadership

  • Troy Wilson, PhD, JD, Board Chair and Co-Founder, Chief Executive Officer and Director, Kura Oncology
  • Carsten Boess, Board Member
  • Noreen Henig, M.D., Board Member
  • Jean Kim, Board Member
  • Edward Kaye, M.D., Chief Executive Officer and Director, Stoke Therapeutics
  • Simona Skerjanec, Board Member
  • Tamar Thompson, VP, Govt. Affairs and Policy, Alexion Pharmaceuticals
  • Sarah Boyce, President & Chief Executive Officer, Avidity Biosciences
  • Arthur A. Levin, PhD, Distinguished Scientist and Strategic Leader, Avidity Biosciences

Last updated: 2024-12-31